Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 19Lymphoma, Non-Hodgkin 11Hodgkin Disease 10Leukemia, Biphenotypic, Acute 8Multiple Myeloma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Burkitt Lymphoma 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Neuroblastoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Anemia, Refractory, with Excess of Blasts 5Recurrence 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Breast Neoplasms 4Lymphoma, T-Cell 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Rhabdomyosarcoma 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2Myelodysplastic-Myeloproliferative Diseases 2Medulloblastoma 2

Interventions

Magnetic Resonance Spectroscopy 9Cyclophosphamide 7X-Rays 6Temozolomide 6Specimen Handling 6Phantoms, Imaging 6Biopsy 6Nuclear Medicine Department, Hospital 5Etoposide 5Nivolumab 4Bevacizumab 4Radiation 3Irinotecan 3Automobiles 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2lutetium Lu 177 dotatate 2larotrectinib 2ivosidenib 2etoposide phosphate 2erdafitinib 2ensartinib 2abemaciclib 2Watchful Waiting 2Radiotherapy 2ONC206 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × Granulocyte Colony-Stimulating Factor × 1 year × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡